Tag: Competition

Displaying 1441 - 1460 of 1823 results.

The Federal Trade Commission today filed a motion in U.S. District Court for the District of Columbia, pursuant to Section 7A(g)(2) of the Clayton Act, 15 U.S.C. § 18a(g)(2), to require Blockbuster, Inc. to comply with the statutory rules of the Hart-Scott-Rodino Act (HSR).
The order prohibits Preferred Health Services from orchestrating collective agreements and other terms for physician services when negotiating with health insurance plans and other third party payers. According to the complaint these agreements among the physician-hospital...
Under a consent order announced today by the Federal Trade Commission, Preferred Health Services, Inc. (Preferred Health), a physician-hospital organization consisting of more than 100 doctors and the Oconee Memorial Hospital in northwestern South Carolina, has been barred from collectively...
A final consent order requires Cytec Industries, Inc. to divest UCB’s Amino Resins Business in Massachusetts and Germany to a Commission-approved buyer. According to the complaint issued with the agreement, the acquisition as proposed would eliminate direct competition between the...
The Federal Trade Commission has released a study on the strength of competition in the sale of prescription contact lenses. Congress required the study under the Fairness to Contact Lens Consumers Act (FCLCA), which was enacted to promote competition in the contact lens market by enhancing...
Cemex S.A. agreed to settle concerns stemming from its proposed $5.8 billion acquisition of RMC Group PLC. Under terms of the proposed consent order, Cemex will divest RMC's five ready-mix concrete plants in the Tucson, Arizona area, at no minimum price to a Commission- approved...
Commission authorization of the staff to file amicus brief: The Commission has authorized the staff to file a brief as amicus curiae in Teva Pharmaceuticals USA, Inc. v. Pfizer, Inc., Case No. 04-1186 (Fed. Cir.) in support of Teva’s petition for rehearing or rehearing en banc. The case, which was...
Commission approval of final consent order: Following a public comment period, the Commission has approved a final consent order in the matter concerning Genzyme Corporation and ILEX Oncology, Inc. The Commission vote approving the final consent order was 4-0-1, with Commissioner Pamela Jones...
The Commission has approved a petition for proposed divestiture received from General Electric Company (GE) and related to the FTC decision and order regarding GE’s acquisition of InVision Technologies (InVision). Under the terms of the order, within six months of the execution date the consent...
A consent order allowed Genzyme’s acquisition of ILEX Oncology, Inc., but requires the companies to divest certain assets in the market for solid organ transplant acute therapy drugs. Specifically, Genzyme is required to divest all contractual rights related to ILEX’s Campath®, an...
The Federal Trade Commission today announced that it will conditionally allow Genzyme Corporation’s (Genzyme) proposed $1 billion acquisition of ILEX Oncology, Inc. (Ilex), provided the companies divest overlapping assets in the U.S. market for solid organ transplant (SOT) acute therapy drugs....
The attorneys general of several states (the States) today announced their submission, for approval by the U.S. District Court for the District of New Jersey, of a settlement agreement with Akzo Nobel, N.V., and its subsidiary, Organon USA Inc. (collectively, Organon), resolving the States'...
Enterprise Products Partners L.P. settled charges that its $13 billion merger with GulfTerra Energy/Partners L.P. would eliminate competition in two markets: the pipeline transportation of natural gas from the West Central Deepwater region of the Gulf of Mexico; and propane storage...
The Federal Trade Commission today announced that Enterprise Products Partners L.P. (Enterprise) has agreed to make several divestitures to settle allegations that the $13 billion merger of Enterprise and GulfTerra Energy Partners L.P. (GulfTerra) would harm competition.
Under terms of a consent order, Magellan completed its acquisition of pipelines and terminals in the Midwestern United States and a refined petroleum products terminal in Oklahoma City that supplies light petroleum products such as gasoline and diesel fuel from the Shell Oil Company...
Under the terms of a consent agreement with the Federal Trade Commission announced today, Magellan Midstream Partners, L.P. (Magellan) will be able to complete its proposed $492.4 million acquisition of selected pipeline and terminal assets from Royal Dutch Petroleum Company (Shell), provided it...
A consent order settled charges that the White Sands Health Care System refused to deal with health care insurers that resisted the collectively negotiated prices set by its member physicians and nurse anesthetists. The complaint alleged that these practices increased costs for...
The consent order settled charges that Buckeye's proposed acquisition of five refined petroleum products pipelines and 24 petroleum products terminals in the United States from Shell Oil Company would reduce competition in the market for the terminaling of gasoline, diesel fuel, and...

Pages